Literature DB >> 15597656

Comparison of laparoscopic radical renal surgery in morbidly obese and non-obese patients.

Anil Kapoor1, Anmar Nassir, Ben Chew, Aubrey Gillis, Patrick Luke, Paul Whelan.   

Abstract

BACKGROUND AND
PURPOSE: Laparoscopic radical nephrectomy is rapidly becoming accepted as the preferred management of low-stage renal masses not amenable to partial nephrectomy. Minimally invasive surgery is advantageous to decrease perioperative and postoperative morbidity and allows patients to return to normal activities faster. Obesity has been a relative contraindication to this technique, and these patients have traditionally undergone open surgery. We present a review of 23 morbidly obese patients in comparison with patients who were not morbidly obese who underwent radical laparoscopic nephrectomy and nephroureterectomy at our institution. PATIENTS AND METHODS: Hospital charts between April 2001 and October 2003 were reviewed for morbidly obese patients undergoing transperitoneal laparoscopic renal surgery who were compared with age- and sex-matched control patients who underwent laparoscopic renal surgery in the same institution for similar indications. The data were collected at the time of the surgery.
RESULTS: Twenty-three patients with a mean BMI of 42.2 kg/m2 underwent successful transperitoneal laparoscopic surgery. The mean specimen mass was 865 g, which was significantly larger than in the control group. The mean operative time was 200 minutes, which was around half an hour longer than in the matched group. The mean estimated blood loss was 243 mL, which was comparable to that of the controls. There were two perioperative complications, and the mean hospital stay was 4.5 days, 1 day longer than in the control group.
CONCLUSIONS: Laparoscopic transperitoneal renal surgery is technically more difficult in morbidly obese patients but is a feasible, effective, minimally invasive method of removing renal malignancies. It offers decreased respiratory and cardiac morbidity in this higher-risk population. This study showed a complication profile similar to that in non-obese patients.

Entities:  

Mesh:

Year:  2004        PMID: 15597656     DOI: 10.1089/end.2004.18.657

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

Review 1.  Partial Nephrectomy in the Overweight Patient: an Overview.

Authors:  Ben Schurhamer; Nathan Littlejohn; Ehab Eltahawy; Rodney Davis; Mohamed Kamel
Journal:  Curr Urol Rep       Date:  2016-01       Impact factor: 3.092

2.  Current status of robot-assisted laparoscopic partial nephrectomy.

Authors:  Keng-Siang Png; Chandru P Sundaram
Journal:  Indian J Surg Oncol       Date:  2011-10-07

Review 3.  Complications of Minimally Invasive Surgery and Their Management.

Authors:  Joshua R Kaplan; Ziho Lee; Daniel D Eun; Adam C Reese
Journal:  Curr Urol Rep       Date:  2016-06       Impact factor: 3.092

4.  Obesity is an adverse factor on laparoscopic radical nephrectomy for t2 but not t1 renal cell carcinoma.

Authors:  Se Yun Kwon; Jae Jun Bae; Jung Gon Lee; Seock Hwan Choi; Bum Soo Kim; Eun Sang Yoo; Tae Gyun Kwon; Tae-Hwan Kim
Journal:  Korean J Urol       Date:  2011-08-22

5.  Predicting primary postoperative pulmonary complications in patients undergoing minimally invasive surgery for colorectal cancer.

Authors:  Mohamed A Abd El Aziz; William R Perry; Fabian Grass; Kellie L Mathis; David W Larson; Jay Mandrekar; Kevin T Behm
Journal:  Updates Surg       Date:  2020-10-01

6.  Assessment of Clavien-Dindo classification in patients >75 years undergoing nephrectomy/nephroureterectomy.

Authors:  Atif Khan; Victor Palit; Andy Myatt; Jon J Cartledge; Anthony J Browning; Adrian D Joyce; Chandra Shekhar Biyani
Journal:  Urol Ann       Date:  2013-01

7.  Laparoscopic radical nephrectomy in extremely obese patients.

Authors:  Bartosz Małkiewicz; Tomasz Szydełko; Janusz Dembowski; Krzysztof Tupikowski; Romuald Zdrojowy
Journal:  Cent European J Urol       Date:  2012-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.